Effect of internal limiting membrane peeling on long-term visual outcomes for diabetic macular edema

Retina

Volumn 35, Issue 7, 2015, Pages 1422-1428

  Kumagai, Kazuyuki ^a   Hangai, Masanori ^b   Ogino, Nobuchika ^a   Larson, Eric ^c  

^a Shinjo Ophthalmologic Institute   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c Miyazaki Prefectural Nursing University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLINDNESS; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; EPIRETINAL MEMBRANE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTERNAL LIMITING MEMBRANE PEELING; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOVASCULAR GLAUCOMA; PARS PLANA VITRECTOMY; PERIPHERAL RETINAL BREAK; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETINA DETACHMENT; RETINA EXUDATE; RETINA SURGERY; VISUAL ACUITY; VISUAL ACUITY CHART; VITRECTOMY; VITREOUS BODY DETACHMENT; AGED; BASEMENT MEMBRANE; DIABETIC RETINOPATHY; EYE SURGERY; MACULAR EDEMA; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BASEMENT MEMBRANE; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE COMPLICATIONS; MACULAR EDEMA; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; VISUAL ACUITY; VITRECTOMY;

EID: 84942577402     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000497     Document Type: Article

References (66)

1. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. IV: diabetic macular edema. Ophthalmology 1984;91:1464-1474.
2. Klein R, Moss SE, Klein BE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989;96:1501-1510.
3. Johnson MW. Etiology and treatment of macular edema. Am J Ophthalmol 2009;147:11-21.
4. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-427.
5. Haritoglou C, Kook D, Neubauer A, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
6. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753-759.
7. Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996; 121:405-413.
8. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996;122: 258-260.
9. Ikeda T, Sato K, Katano T, Hayashi Y. Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophthalmol 1999;83:12-14.
10. Pendergast SD, Hassan TS, Williams GA, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 2000;130:178-186.
11. La Heij EC, Hendrikse F, Kessels AG, Derhaag PJ. Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 2001;239:264-270.
12. Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 2001;132:369-377.
13. Otani T, Kishi S. A controlled study of vitrectomy for diabetic macular edema. Am J Ophthalmol 2002;134:214-219.
14. Sato Y, Lee Z, Shimada H. Vitrectomy for diabetic cystoid macular edema. Jpn J Ophthalmol 2002;46:315-322.
15. Kojima T, Terasaki H, Nomura H, et al. Vitrectomy for diabetic macular edema: effect of glycemic control (HbA(1c)), renal function (creatinine) and other local factors. Ophthalmic Res 2003;35:192-198.
16. Yamamoto T, Hitani K, Tsukahara I, et al. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Am J Ophthalmol 2003;135:14-19.
17. Massin P, Duguid G, Erginay A, et al. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 2003;135:169-177.
18. Parolini B, Panozzo G, Gusson E, et al. Diode laser, vitrectomy and intravitreal triamcinolone. A comparative study for the treatment of diffuse non tractional diabetic macular edema. Semin Ophthalmol 2004;19:1-12.
19. Shimonagano Y, Makiuchi R, Miyazaki M, et al. Results of visual acuity and foveal thickness in diabetic macular edema after vitrectomy. Jpn J Ophthalmol 2007;51:204-209.
20. Shimonagano Y, Doi N, Noda Y, et al. Recurrence of diabetic macular edema after intravitreous injection of triamcinolone following vitrectomy. Jpn J Ophthalmol 2007;51:278-284.
21. Yamamoto T, Takeuchi S, Sato Y, Yamashita H. Long-term follow-up results of pars plana vitrectomy for diabetic macular edema. Jpn J Ophthalmol 2007;51:285-291.
22. Gandorfer A, Messmer EM, UlbigMW, Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000;20:126-133.
23. Dillinger P, Mester U. Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 2004;242:630-637.
24. Radetzky S, Walter P, Fauser S, et al. Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2004;242: 273-278.
25. Avci R, Kaderli B, Avci B, et al. Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular edema. Graefes Arch Clin Exp Ophthalmol 2004;242:845-852.
26. Kuhn F, Kiss G, Mester V, et al. Vitrectomy with internal limiting membrane removal for clinically significant macular oedema. Graefes Arch Clin Exp Ophthalmol 2004;242:402-408.
27. Jahn CE, Töpfner von Schutz K, Richter J, et al. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy. Ophthalmologica 2004; 218:378-384.
28. Thomas D, Bunce C, Moorman C, Laidlaw DA. A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema. Br J Ophthalmol 2005;89:81-86.
29. Rosenblatt BJ, Shah GK, Sharma S, Bakal J. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol 2005;243:20-25.
30. Kimura T, Kiryu J, Nishiwaki H, et al. Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina 2005;25:454-461.
31. Recchia FM, Ruby AJ, Carvalho Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol 2005;139:447-454.
32. Stolba U, Binder S, Gruber D, et al. Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 2005;140: 295-301.
33. Shah SP, Patel M, Thomas D, et al. Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study. Br J Ophthalmol 2006;90:33-36.
34. Higuchi A, Ogata N, Jo N, et al. Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide. Jpn J Ophthalmol 2006;50:529-531.
35. Yanyali A, Nohutcu AF, Horozoglu F, Celik E. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Am J Ophthalmol 2005;139:795-801.
36. Yanyali A, Horozoglu F, Celik E, et al. Pars plana vitrectomy and removal of the internal limiting membrane in diabetic macular edema unresponsive to grid laser photocoagulation. Eur J Ophthalmol 2006;16:573-581.
37. Yanyali A, Horozoglu F, Celik E, Nohutcu AF. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina 2007;27: 557-566.
38. Hartley KL, Smiddy WE, Flynn HW Jr, Murray TG. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina 2008;28:410-419.
39. Dehghan MH, Salehipour M, Naghib J, et al. Pars plana vitrectomy with internal limiting membrane peeling for refractory diffuse diabetic macular edema. J Ophthalmic Vis Res 2010;5: 162-167.
40. Haller JA, Qin H, Apte RS, et al. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 2010;117:1087-1093.
41. Flaxel CJ, Edwards AR, Aiello LP, et al. Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network. Retina 2010;30:1488-1495.
42. Kumagai K, Ogino N, Furukawa M, et al. Internal limiting membrane peeling in vitreous surgery for diabetic macular edema. Nippon Ganka Gakkai Zasshi 2002;106:590-594.
43. Stefaniotou M, Aspiotis M, Kalogeropoulos C, et al. Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol 2004; 14:137-143.
44. Yamamoto T, Hitani K, Sato Y, et al. Vitrectomy for diabetic macular edema with and without internal limiting membrane removal. Ophthalmologica 2005;219:206-213.
45. Bahadir M, Ertan A, Mertoglu O. Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema. Int Ophthalmol 2005;26:3-8.
46. Kamura Y, Sato Y, Isomae T, Shimada H. Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients. Jpn J Ophthalmol 2005;49:297-300.
47. Kralinger MT, Pedri M, Kralinger F, et al. Long-term outcome after vitrectomy for diabetic macular edema. Ophthalmologica 2006;220:147-152.
48. Bardak Y, Cekic O, Tig SU. Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular edema. Eye 2006;20:1357-1359.
49. Mochizuki Y, Hata Y, Enaida H, et al. Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema. Retina 2006;26:143-148.
50. Patel JI, Hykin PG, Schadt M, et al. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 2006;26:5-13.
51. Kumagai K, Furukawa M, Ogino N, et al. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina 2009;29:464-472.
52. Shiba T, Kamura Y, Yagi F, Sato Y. Comparison of surgical procedures for vitreous surgery in diabetic macular edema. Jpn J Ophthalmol 2009;53:120-124.
53. Hoerauf H, Brüggemann A, Muecke M, et al. Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial. Graefes Arch Clin Exp Ophthalmol 2011;249: 997-1008.
54. Yamada Y, Suzuma K, Ryu M, et al. Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling. Curr Eye Res 2013;38:1261-1265.
55. Sonoda K, Sakamoto T, Enaida H, et al. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 2004;111:226-230.
56. Kohno T, Sorgente N, Goodnight R, Ryan S. Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophthalmol Vis Sci 1987;28:515-521.
57. Matsunaga N, Ozeki H, Hirabayashi Y, et al. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina 2005; 25:311-316.
58. Tamura K, Yokoyama T, Ebihara N, Murakami A. Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema. Jpn J Ophthalmol 2012;56:280-287.
59. Kalvoda J, Duskova J, Kubena A, et al. Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2009;247:1307-1314.
60. Kumagai K, Furukawa M, Ogino N, et al. Long-term visual outcomes after vitrectomy for macular edema with foveal hemorrhage in branch retinal vein occlusion. Retina 2007;27: 584-588.
61. Arai M, Yamamoto S, Mitamura Y, et al. Efficacy of vitrectomy and internal limiting membrane removal for macular edema associated with branch retinal vein occlusion. Ophthalmologica 2009;223:172-176.
62. Kumagai K, Furukawa M, Ogino N, Larson E. Possible effects of internal limiting membrane peeling in vitrectomy for macular vein occlusion. Jpn J Ophthalmol 2010;54:61-65.
63. Furukawa M, Kumagai K, Ogino N, Yoshida Y. Peeling of internal limiting membrane for macular edema secondary to central retinal vein occlusion. Jpn J Clin Ophthalmol 2004; 58:2275-2279.
64. Mirza RG, Johnson MW, Jampol LM. Optical coherence tomography use in evaluation of the vitreoretinal interface: a review. Surv Ophthalmol 2007;52:397-421.
65. Gaucher D, Tadayoni R, Erginay A, et al. Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema. Am J Ophthalmol 2005;139:807-813.
66. Abe S, Yamamoto T, Kashiwagi Y, et al. Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema. Jpn J Ophthalmol 2013;57:553-562.